Description
Retatrutide/Cagrilintide 12.5mg/2.5mg is a research blend combining a multi-receptor incretin compound with an amylin-related research analog. It is intended for laboratory studies examining GLP-1, GIP, glucagon, and amylin-associated signaling pathways.

Reviews
There are no reviews yet.